News

ICON plc announces the results of research evaluating patient-centric and patient-designed informed consent formats from Carnegie Mellon University.

This 3-part series provides insight into ensuring compliance with the ICH E6 (R2) Addendum to take effect later this year. Part 1 covers the addendums implications, objectives, requirements and advantages.

Faced with new EMA guidance on anonymizing clinical trial data, drug manufacturers have two choices – do what it takes to meet the November deadline and prioritize clinical study reports, or embrace a more sustainable strategy that starts with the patient-level data.

The Society for Clinical Research Sites (SCRS) announces that Greenphire has joined its Global Impact Partner (GIP) program.

WCCT Global, an international clinical research organization, and Medelis Inc., an oncology clinical research organization announce a merger.

European forum tackles the problem of limited elderly patients involved in clinical trials.

Survey reveals mixed adoption of paperless data collection in clinical trials, pointing to the need for greater alignment of new eClinical technologies and study conduct.

Recent FDA draft guidance pushes for the use of electronic health record data in clinical investigations-and synching EHRs with research systems.

CDER official comments on the significance of ICH's new alternative path for identifying the cardiac safety issue of QT prolongation in non-cardiac drugs.

Why electronic informed consent is key to supporting today’s patient-centric mantra in clinical trials.

Click the title above to open the Applied Clinical Trials June/July 2016 issue in an interactive PDF format.

CRF Health announces reporting enhancements to its TrialManager platform for real-time analysis and management of data collected in clinical trials.

Quintiles announces its Precision Enrollment offering to accelerate site start-up and patient recruitment in oncology clinical trials.

ZRG Partners announce data for the first quarter of 2016 Global Life Sciences Hiring Index.

Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, announced the release of its upgraded Patient Reminders tool.

Bioclinica releases OnPoint Direct, a Clinical Trial Management System geared toward mid-market biopharma and CROs.

Identity trust platforms assure clinical investigators that their credentials are legitimate by allowing use of a single identity that can be recognized across multiple entities. These platforms support collaboration by allowing drug development participants to access data, sign and exchange documents.

Regardless of whether the UK does decide to leave the EU or not, the concern over medication will remain for the rest of Europe. The needs of these countries will persist at a human and public health level for more effective medicines and more effective ways of paying for them.